8,600 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Acquired by Carlson Capital L.P.

Carlson Capital L.P. purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 8,600 shares of the exchange traded fund’s stock, valued at approximately $775,000. SPDR S&P Biotech ETF comprises 0.5% of Carlson Capital L.P.’s investment portfolio, making the stock its 16th largest position.

Other hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC increased its position in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $88.25 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a market cap of $5.82 billion, a PE ratio of 11.47 and a beta of 0.93. The business’s fifty day moving average is $91.11 and its 200-day moving average is $95.87.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.